FDA Investigator Eduardo Carbonell
Eduardo Carbonell has conducted inspections on 44 sites in 1 countries as of 28 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
44
Last Inspection Date:
28 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Eduardo Carbonell:
Aaron F Coleman,
Adriana D Perez,
Alexander B Anderson,
Anabel Veiga,
Andrew J Mcguffin,
Angela F Orozco,
Beira Montalvo,
Benita C Okeke,
Bill Tacket, Jr,
Bora Veliu,
Brandon J Brookens,
Brant M Schroeder,
Brian M Carril,
Christopher T Smith,
Cindy Laboy,
Clara E Santiago,
Craig A Garmendia,
Dawn M Mccabe,
Dawne M Hines,
Dionne D Arline,
Earl Echon,
Edwin J Gorney,
Emily A Baldwin,
Emily A Green,
Eric R Holm,
Gabriel E Muniz,
Gale E Ryan,
Giovanna Serpa,
Glenn S Quintanilla,
Heather M Bullock,
Hector Vallellanes,
Jacqueline E Manjone,
James To Neal,
Jason P Aun,
Jennifer Caycedo,
Jennifer L Huntington,
Jennifer Lalama,
Joanne E King,
John J Bernal,
Jose Perez Soto,
Karen M Rodriguez,
Karissa J Mccaw,
Karl D Hezel,
Katherine M Taylor,
Kelly M Byers,
Krista B Jones,
Laura M Lopez,
LCDR Angelica M Chica,
Leah M Tapley,
Leslin M Coachman,
Lissette Paiz,
LT Mark A Chen, MPH,
LT Richard A Lyght,
Marc Balzarini,
Maria D Jiron,
Marinee Flores Marrero,
Matthew B Thomaston,
Megan K Otero,
Melinda B Lewis,
Mendoza,
Michael C Lombardi,
Myriam Perdomo Pabon,
Nicole M Bell,
Omayra Nrodriguez Ruiz,
Ormond,
Pablo Alcantara,
Paul H Dakin,
Rachel A Gomez,
Rachel A Peters,
Ramon H Pabon Aponte,
Raymond A Lyn, Jr,
Reynolds,
Rina Bhikha,
Robert J Goldman,
Robert W Calais,
Ruth A Williams,
Sally Gopaul,
Sharon Giamberini,
Sheila P Barthelemy,
Stacey L Witherwax,
Stephanie C Milan,
Suzanne A Lovelady,
Teresa I Navas,
Timothy A Tennell,
Vernon L O'neil
Eduardo Carbonell's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2022 | FDA 483 | Tropichem Research Labs, LLC dba Vetio - Form 483, 2022-07-01 |
September, 2000 | EIR | Optimus Inc. d/b/a/ Markys Caviar - EIR, 2000-09-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more